Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-29T18:08:15.086Z Has data issue: false hasContentIssue false
  • English
  • Français

Clozapine in a patient with treatment-resistant schizophrenia and hypertrophic cardiomyopathy: a case report — ADDENDUM

Published online by Cambridge University Press:  13 June 2019

Asiel Yair Adan Sanchez ,
Jessica J. Foster ,
Carla M. Plymen  and
Sukhi Shergill
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
Addendum
Information
BJPsych Open , Volume 5 , Issue 4 , July 2019 , e51
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCND
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-ncnd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
Copyright
Copyright © The Royal College of Psychiatrists 2019

There was an oversight regarding the acknowledgement of funding from the European Research Council, which was a contractual obligation for the funding. Professor Sukhi Shergill was funded by an ERC Consolidator Award.

References

Sanchez, AYA, Foster, JJ, Plymen, CM and Shergill, S. Clozapine in a patient with treatment-resistant schizophrenia and hypertrophic cardiomyopathy: a case report. BJPsych Open 2016; 2: 390–393.10.1192/bjpo.bp.116.003723Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.